Category: Medication news

In 2023, promethazine was the 230th most commonly prescribed medication in the United States, with over 1 million prescriptions [1.3.4]. Despite its widespread use, questions often arise: **has promethazine been discontinued?** While some specific brands and formulations are no longer produced, generic promethazine remains available.

In 2025, an estimated 18.3% of U.S. adults are currently experiencing or being treated for depression [1.8.1]. For many, a key question is affordability, which leads them to ask: **Has Viibryd gone generic?** The answer is yes, offering a more accessible treatment option.

With a history tracing back to 1500 BC, colchicine is one of the oldest medicines still in use [1.8.3]. So, was colchicine taken off the market? The answer is complex: unapproved versions were, but FDA-approved forms remain available.

Since its FDA approval in 2018, Aimovig (erenumab-aooe) has been a key player in migraine prevention [1.2.5]. Despite rumors, if you're asking 'Why was Aimovig discontinued?', the simple answer is: it hasn't been. The confusion stems from a significant change in its commercial partnership.

An estimated 34% of American adults were obese in 2007-2008, driving demand for prescription weight management aids [1.7.3]. The question of *Has Didrex been discontinued?* is complex; while the brand name is gone, the active ingredient remains available [1.2.3, 1.2.4].

Suboxone is a key medication in treating opioid use disorder, with its active ingredient buprenorphine being a gold standard in treatment. The question 'Why are they discontinuing Suboxone?' stems from a crucial market shift, not an abandonment of the therapy.

Synribo (omacetaxine mepesuccinate) was permanently discontinued due to manufacturing issues, with remaining inventory expected to be exhausted in late 2023. This article explores the detailed reasons for its withdrawal and its place in cancer therapy.